Medication comparison
Ozempic vs Wegovy vs Zepbound
Ozempic, Wegovy and Zepbound are often discussed together online, but they are not interchangeable labels. Ozempic and Wegovy both contain semaglutide, while Zepbound contains tirzepatide. The bigger difference for a shopper is the FDA-approved use, dose path, safety label and whether a provider is discussing on-label or off-label treatment.
Best fit
- Readers trying to understand semaglutide versus tirzepatide before comparing providers.
- People checking whether a quoted medication is FDA-approved for weight management.
- Users who need clear language before a telehealth intake or pharmacy quote.
Watch-outs
- Ozempic is not the same label as Wegovy even though both use semaglutide.
- Zepbound uses tirzepatide, not semaglutide.
- All three labels include serious safety warnings and contraindications that require clinician review.
Active ingredient and label are separate questions
Ozempic and Wegovy both contain semaglutide, but the label, dose schedule and approved-use language differ. Ozempic's FDA label is built around type 2 diabetes uses and related risk-reduction language. Wegovy's label is built around chronic weight management, cardiovascular risk-reduction language for selected adults and other current label details. Zepbound is different again because it contains tirzepatide, a GIP/GLP-1 receptor agonist, and has its own prescribing information.
- Same active ingredient does not mean same product label.
- Ask whether the provider is using a medication on-label or off-label.
- Use FDA labels, not social posts, as the source of truth for approved uses.
Weight-management comparison
If the question is chronic weight management, Wegovy and Zepbound are the cleaner starting points because their official labels include weight-management uses. Ozempic may still appear in provider conversations, but for weight loss that usually means off-label prescribing. Off-label use is a clinician decision, not a marketing shortcut, and it should come with clear explanation of risks, alternatives and monitoring.
- Do not assume Ozempic is FDA-approved for weight loss because it is a GLP-1 medicine.
- Compare Wegovy and Zepbound using their own labels and dose paths.
- Ask how side effects, missed doses and contraindications are handled.
Safety and cost checks before choosing
All three products have prescribing information that clinicians use to screen for contraindications, warnings, drug interactions and adverse reactions. Cost comparisons also need precision: insurance may treat diabetes and obesity indications differently, and cash-pay pricing can differ by product, dose, pharmacy and savings program. The safest consumer workflow is to confirm the exact brand, active ingredient, indication and total out-of-pocket cost before paying a provider.
- Confirm brand name, active ingredient and dosage form.
- Check whether insurance approval depends on diagnosis or prior authorization.
- Review boxed warnings and contraindications with a licensed clinician.
Educational content only. Do not use this page as medical advice or as a substitute for a licensed clinician, pharmacist or insurer reviewing your situation.